HLA Class I Binding Promiscuity of the CD8 T-Cell Epitopes of Human Papillomavirus Type 16 E6 Protein
- 1 February 2007
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 81 (3) , 1412-1423
- https://doi.org/10.1128/jvi.01768-06
Abstract
One of the critical steps in the progression to cervical cancer appears to be the establishment of persistent human papillomavirus (HPV) infection. We have demonstrated that the lack of cytotoxic T-lymphocyte response to HPV type 16 (HPV 16) E6 protein was associated with persistence and that the potential presence of dominant CD8 T-cell epitopes was most frequently found (n = 4 of 23) in the E6 16-40 region by examining the pattern of CD8 T-cell epitopes within the E6 protein in women who had cleared their HPV 16 infections. The goal of this study was to define the minimal/optimal amino acid sequences and the HLA restricting molecules of these dominant CD8 T-cell epitopes as well as those of subdominant ones if present. Three dominant epitopes, E6 29-38 (TIHDIILECV; restricted by the HLA-A0201 molecule), E6 29-37 (TIHDIILEC; restricted by B48), and E6 31-38 (HDIILECV; restricted by B4002), and one subdominant epitope, E6 52-61 (FAFRDLCIVY; restricted by B35) were characterized. Taken together with a previously described dominant epitope, E6 52-61 (FAFRDLCIVY; restricted by B57), the CD8 T-cell epitopes demonstrated striking HLA class I binding promiscuity. All of these epitopes were endogenously processed, but the presence of only two of the five epitopes could have been predicted based on the known binding motifs. The HLA class I promiscuity which has been described for human immunodeficiency virus may be more common than previously recognized.Keywords
This publication has 52 references indexed in Scilit:
- Antigen processing is predictable: From genes to T cell epitopesTransplant Immunology, 2005
- Patterns of CD8 T-Cell Epitopes within the Human Papillomavirus Type 16 (HPV 16) E6 Protein among Young Women Whose HPV 16 Infection Has Become UndetectableClinical and Vaccine Immunology, 2005
- Naturally processed and HLA‐B8‐presented HPV16 E7 epitope recognized by T cells from patients with cervical cancerInternational Journal of Cancer, 2005
- T Cell Epitope "Hotspots" on the HIV Type 1 gp120 Envelope Protein Overlap with Tryptic Fragments Displayed by Mass SpectrometryAIDS Research and Human Retroviruses, 2005
- Different Methods of Identifying New Antigenic Epitopes of Human Papillomavirus Type 16 E6 and E7 ProteinsClinical and Vaccine Immunology, 2004
- Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patientsZeitschrift für Krebsforschung und Klinische Onkologie, 2003
- Papillomavirus infections — a major cause of human cancersBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- Studies on in Vivo Induction of Cytotoxic T Lymphocyte Responses by Synthetic Peptides from E6 and E7 Oncoproteins of Human Papillomavirus Type 16Viral Immunology, 1995
- Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cellsEuropean Journal of Immunology, 1993
- Human papillomavirus type 16 DNA sequenceVirology, 1985